| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc19d8d6ba9ad5c1fa5770341472b56 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4743 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate |
1997-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c96cc411dbadf2872bc0f5fed26778cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3916db6409279bddd355e0d6067ebfc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_750670562718cb16c361a0883c793acb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_110e489150649b95d17158841f6bec3b |
| publicationDate |
1999-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5872220-A |
| titleOfInvention |
Antibodies to insulin-like growth factor binding protein IGFBP-6 |
| abstract |
A purified binding protein selected from the group consisting of insulin-like growth factor binding protein having an amino acid sequence which is at least 85% homologous to the amino acid sequence of FIG. 1 and fragments thereof comprising at least 10 consecutive amino acids of the sequence that are capable of binding to an antibody specific for the protein or to an insulin-like growth factor is described. Recombinant DNA molecules encoding the binding proteins and subsequences thereof are also described along with recombinant microorganisms and cell lines containing the DNA molecules and methods for preparing the binding proteins by growing the recombinant hosts containing the relevant DNA molecules. Antibodies to the protein, identified as IGFBP-6, which are useful in various diagnostic applications, are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8574578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7972600-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8128929-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7638605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425911-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009110678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009175868-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008025990-A1 |
| priorityDate |
1990-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |